1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Zhou, M.-M.
Huang, B.
Olejniczak, E.T.
Meadows, R.P.
Shuker, S.B.
Miyazaki, M.
Trub, T.
Shoelson, S.E.
Feisk, S.W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C9 H12 N O6 P
261.168
n
O-PHOSPHOTYROSINE
PHOSPHONOTYROSINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
3
388
393
10.1038/nsb0496-388
8599766
Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain.
1996
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
270
27407
Ptb Domains of Irs-1 and Shc Have Distinct But Overlapping Binding Specificities
1995
UK
Nature
NATUAS
0006
0028-0836
378
584
Structure and Ligand Recognition of the Phosphotyrosine Binding Domain of Shc
1995
US
Mol.Cell.Biol.
MCEBD4
2044
0270-7306
14
6433
Characterization of an Interaction between Insulin Receptor Substrate 1 and the Insulin Receptor by Using the Two-Hybrid System
1994
10.2210/pdb1irs/pdb
pdb_00001irs
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12648.737
IRS-1
PTB DOMAIN
1
man
polymer
1241.311
IL-4 RECEPTOR PHOSPHOPEPTIDE
1
man
polymer
INSULIN RECEPTOR SUBSTRATE 1
no
no
MGPAFKEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGE
FWMQVDDSVVAQNMHETILEAMRAMSDEFRPR
MGPAFKEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGE
FWMQVDDSVVAQNMHETILEAMRAMSDEFRPR
A
polypeptide(L)
no
yes
LVIAGNPA(PTR)RS
LVIAGNPAYRS
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
BL21 (DE2) PLYSS
Escherichia
sample
BL21
PTB DOMAIN OF IRS-1
9606
SKELETAL
Homo sapiens
PTB DOMAIN OF IRS-1
562
Escherichia coli
PET30B
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-05-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_ref_seq_dif.details
Y
BNL
1996-03-22
REL
1
SET OF IDEAL BOND LENGTHS AND ANGLES USED DURING REFINEMENT: PARALLHDG.PRO IN X-PLOR.
BRUNGER
refinement
X-PLOR
MET
156
n
1
MET
156
A
GLY
157
n
2
GLY
157
A
PRO
158
n
3
PRO
158
A
ALA
159
n
4
ALA
159
A
PHE
160
n
5
PHE
160
A
LYS
161
n
6
LYS
161
A
GLU
162
n
7
GLU
162
A
VAL
163
n
8
VAL
163
A
TRP
164
n
9
TRP
164
A
GLN
165
n
10
GLN
165
A
VAL
166
n
11
VAL
166
A
ILE
167
n
12
ILE
167
A
LEU
168
n
13
LEU
168
A
LYS
169
n
14
LYS
169
A
PRO
170
n
15
PRO
170
A
LYS
171
n
16
LYS
171
A
GLY
172
n
17
GLY
172
A
LEU
173
n
18
LEU
173
A
GLY
174
n
19
GLY
174
A
GLN
175
n
20
GLN
175
A
THR
176
n
21
THR
176
A
LYS
177
n
22
LYS
177
A
ASN
178
n
23
ASN
178
A
LEU
179
n
24
LEU
179
A
ILE
180
n
25
ILE
180
A
GLY
181
n
26
GLY
181
A
ILE
182
n
27
ILE
182
A
TYR
183
n
28
TYR
183
A
ARG
184
n
29
ARG
184
A
LEU
185
n
30
LEU
185
A
CYS
186
n
31
CYS
186
A
LEU
187
n
32
LEU
187
A
THR
188
n
33
THR
188
A
SER
189
n
34
SER
189
A
LYS
190
n
35
LYS
190
A
THR
191
n
36
THR
191
A
ILE
192
n
37
ILE
192
A
SER
193
n
38
SER
193
A
PHE
194
n
39
PHE
194
A
VAL
195
n
40
VAL
195
A
LYS
196
n
41
LYS
196
A
LEU
197
n
42
LEU
197
A
ASN
198
n
43
ASN
198
A
SER
199
n
44
SER
199
A
GLU
200
n
45
GLU
200
A
ALA
201
n
46
ALA
201
A
ALA
202
n
47
ALA
202
A
ALA
203
n
48
ALA
203
A
VAL
204
n
49
VAL
204
A
VAL
205
n
50
VAL
205
A
LEU
206
n
51
LEU
206
A
GLN
207
n
52
GLN
207
A
LEU
208
n
53
LEU
208
A
MET
209
n
54
MET
209
A
ASN
210
n
55
ASN
210
A
ILE
211
n
56
ILE
211
A
ARG
212
n
57
ARG
212
A
ARG
213
n
58
ARG
213
A
CYS
214
n
59
CYS
214
A
GLY
215
n
60
GLY
215
A
HIS
216
n
61
HIS
216
A
SER
217
n
62
SER
217
A
GLU
218
n
63
GLU
218
A
ASN
219
n
64
ASN
219
A
PHE
220
n
65
PHE
220
A
PHE
221
n
66
PHE
221
A
PHE
222
n
67
PHE
222
A
ILE
223
n
68
ILE
223
A
GLU
224
n
69
GLU
224
A
VAL
225
n
70
VAL
225
A
GLY
226
n
71
GLY
226
A
ARG
227
n
72
ARG
227
A
SER
228
n
73
SER
228
A
ALA
229
n
74
ALA
229
A
VAL
230
n
75
VAL
230
A
THR
231
n
76
THR
231
A
GLY
232
n
77
GLY
232
A
PRO
233
n
78
PRO
233
A
GLY
234
n
79
GLY
234
A
GLU
235
n
80
GLU
235
A
PHE
236
n
81
PHE
236
A
TRP
237
n
82
TRP
237
A
MET
238
n
83
MET
238
A
GLN
239
n
84
GLN
239
A
VAL
240
n
85
VAL
240
A
ASP
241
n
86
ASP
241
A
ASP
242
n
87
ASP
242
A
SER
243
n
88
SER
243
A
VAL
244
n
89
VAL
244
A
VAL
245
n
90
VAL
245
A
ALA
246
n
91
ALA
246
A
GLN
247
n
92
GLN
247
A
ASN
248
n
93
ASN
248
A
MET
249
n
94
MET
249
A
HIS
250
n
95
HIS
250
A
GLU
251
n
96
GLU
251
A
THR
252
n
97
THR
252
A
ILE
253
n
98
ILE
253
A
LEU
254
n
99
LEU
254
A
GLU
255
n
100
GLU
255
A
ALA
256
n
101
ALA
256
A
MET
257
n
102
MET
257
A
ARG
258
n
103
ARG
258
A
ALA
259
n
104
ALA
259
A
MET
260
n
105
MET
260
A
SER
261
n
106
SER
261
A
ASP
262
n
107
ASP
262
A
GLU
263
n
108
GLU
263
A
PHE
264
n
109
PHE
264
A
ARG
265
n
110
ARG
265
A
PRO
266
n
111
PRO
266
A
ARG
267
n
112
ARG
267
A
LEU
489
n
1
LEU
489
B
VAL
490
n
2
VAL
490
B
ILE
491
n
3
ILE
491
B
ALA
492
n
4
ALA
492
B
GLY
493
n
5
GLY
493
B
ASN
494
n
6
ASN
494
B
PRO
495
n
7
PRO
495
B
ALA
496
n
8
ALA
496
B
PTR
497
n
9
PTR
497
B
ARG
498
n
10
ARG
498
B
SER
499
n
11
SER
499
B
author_defined_assembly
2
dimeric
B
PTR
497
O-PHOSPHOTYROSINE
B
PTR
9
TYR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
GLU
162
A
O
GLU
7
A
N
LEU
187
A
N
LEU
32
A
O
ARG
184
A
O
ARG
29
A
N
VAL
195
A
N
VAL
40
A
O
ILE
192
A
O
ILE
37
A
N
LEU
206
A
N
LEU
51
A
O
GLY
234
A
O
GLY
79
A
N
VAL
225
A
N
VAL
70
A
O
PHE
220
A
O
PHE
65
A
N
SER
217
A
N
SER
62
1
A
ARG
184
0.217
SIDE CHAIN
1
A
ARG
212
0.203
SIDE CHAIN
1
A
ARG
213
0.176
SIDE CHAIN
1
A
ARG
227
0.312
SIDE CHAIN
1
A
ARG
258
0.292
SIDE CHAIN
1
A
ARG
265
0.238
SIDE CHAIN
1
A
ARG
267
0.258
SIDE CHAIN
1
B
ARG
498
0.310
SIDE CHAIN
1
A
PRO
158
-83.94
47.10
1
A
LEU
168
-45.06
157.63
1
A
GLN
175
-150.05
-45.21
1
A
THR
188
-99.16
46.08
1
A
SER
189
38.61
28.74
1
A
LYS
190
169.35
-34.83
1
A
ASN
198
-99.52
37.11
1
A
GLU
200
-133.27
-54.78
1
A
SER
217
-64.14
90.35
1
A
GLU
218
64.01
-88.53
1
A
VAL
240
-107.86
-163.93
1
A
ASP
242
-171.81
-146.93
1
A
PHE
264
-81.13
-70.49
1
A
ARG
265
171.37
145.98
1
A
PRO
266
-55.68
-152.33
1
B
ARG
498
72.84
-81.78
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
IRS-1 PTB DOMAIN COMPLEXED WITH A IL-4 RECEPTOR PHOSPHOPEPTIDE, NMR, MINIMIZED AVERAGE STRUCTURE
1
N
N
2
N
N
A
LEU
173
A
LEU
18
HELX_P
A
THR
176
A
THR
21
1
1
4
A
VAL
245
A
VAL
90
HELX_P
A
ASP
262
A
ASP
107
1
2
18
B
PRO
495
B
PRO
7
HELX_P
B
PTR
497
B
PTR
9
5
3
3
covale
1.309
both
B
ALA
496
B
C
ALA
8
1_555
B
PTR
497
B
N
PTR
9
1_555
covale
1.309
both
B
PTR
497
B
C
PTR
9
1_555
B
ARG
498
B
N
ARG
10
1_555
COMPLEX (SIGNAL TRANSDUCTION/PEPTIDE)
PHOSPHOTYROSINE BINDING DOMAIN (PTB), COMPLEX, SIGNAL TRANSDUCTION, COMPLEX (SIGNAL TRANSDUCTION-PEPTIDE), COMPLEX (SIGNAL TRANSDUCTION-PEPTIDE) complex
IRS1_HUMAN
UNP
1
1
P35568
MASPPESDGFSDVRKVGYLRKPKSMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESCFNINKRADSKN
KHLVALYTRDEHFAIAADSEAEQDSWYQALLQLHNRAKGHHDGAAALGAGGGGGSCSGSSGLGEAGEDLSYGDVPPGPAF
KEVWQVILKPKGLGQTKNLIGIYRLCLTSKTISFVKLNSEAAAVVLQLMNIRRCGHSENFFFIEVGRSAVTGPGEFWMQV
DDSVVAQNMHETILEAMRAMSDEFRPRSKSQSSSNCSNPISVPLRRHHLNNPPPSQVGLTRRSRTESITATSPASMVGGK
PGSFRVRASSDGEGTMSRPASVDGSPVSPSTNRTHAHRHRGSARLHPPLNHSRSIPMPASRCSPSATSPVSLSSSSTSGH
GSTSDCLFPRRSSASVSGSPSDGGFISSDEYGSSPCDFRSSFRSVTPDSLGHTPPARGEEELSNYICMGGKGPSTLTAPN
GHYILSRGGNGHRCTPGTGLGTSPALAGDEAASAADLDNRFRKRTHSAGTSPTITHQKTPSQSSVASIEEYTEMMPAYPP
GGGSGGRLPGHRHSAFVPTRSYPEEGLEMHPLERRGGHHRPDSSTLHTDDGYMPMSPGVAPVPSGRKGSGDYMPMSPKSV
SAPQQIINPIRRHPQRVDPNGYMMMSPSGGCSPDIGGGPSSSSSSSNAVPSGTSYGKLWTNGVGGHHSHVLPHPKPPVES
SGGKLLPCTGDYMNMSPVGDSNTSSPSDCYYGPEDPQHKPVLSYYSLPRSFKHTQRPGEPEEGARHQHLRLSTSSGRLLY
AATADDSSSSTSSDSLGGGYCGARLEPSLPHPHHQVLQPHLPRKVDTAAQTNSRLARPTRLSLGDPKASTLPRAREQQQQ
QQPLLHPPEPKSPGEYVNIEFGSDQSGYLSGPVAFHSSPSVRCPSQLQPAPREEETGTEEYMKMDLGPGRRAAWQESTGV
EMGRLGPAPPGAASICRPTRAVPSSRGDYMTMQMSCPRQSYVDTSPAAPVSYADMRTGIAAEEVSLPRATMAAASSSSAA
SASPTGPQGAAELAAHSSLLGGPQGPGGMSAFTRVNLSPNRNQSAKVIRADPQGCRRRHSSETFSSTPSATRVGNTVPFG
AGAAVGGGGGSSSSSEDVKRHSSASFENVWLRPGELGGAPKEPAKLCGAAGGLENGLNYIDLDLVKDFKQCPQECTPEPQ
PPPPPPPHQPLGSGESSSTRRSSEDLSAYASISFQKQPEDRQ
IL4RA_HUMAN
UNP
2
1
P24394
MGWLCSGLLFPVSCLVLLQVASSGNMKVLQEPTCVSDYMSISTCEWKMNGPTNCSTELRLLYQLVFLLSEAHTCIPENNG
GAGCVCHLLMDDVVSADNYTLDLWAGQQLLWKGSFKPSEHVKPRAPGNLTVHTNVSDTLLLTWSNPYPPDNYLYNHLTYA
VNIWSENDPADFRIYNVTYLEPSLRIAASTLKSGISYRARVRAWAQCYNTTWSEWSPSTKWHNSYREPFEQHLLLGVSVS
CIVILAVCLLCYVSITKIKKEWWDQIPNPARSRLVAIIIQDAQGSQWEKRSRGQEPAKCPHWKNCLTKLLPCFLEHNMKR
DEDPHKAAKEMPFQGSGKSAWCPVEISKTVLWPESISVVRCVELFEAPVECEEEEEVEEEKGSFCASPESSRDDFQEGRE
GIVARLTESLFLDLLGEENGGFCQQDMGESCLLPPSGSTSAHMPWDEFPSAGPKEAPPWGKEQPLHLEPSPPASPTQSPD
NLTCTETPLVIAGNPAYRSFSNSLSQSPCPRELGPDPLLARHLEEVEPEMPCVPQLSEPTTVPQPEPETWEQILRRNVLQ
HGAAAAPVSAPTSGYQEFVHAVEQGGTQASAVVGLGPPGEAGYKAFSSLLASSAVSPEKCGFGASSGEEGYKPFQDLIPG
CPGDPAPVPVPLFTFGLDREPPRSPQSSHLPSSSPEHLGLEPGEKVEDMPKPPLPQEQATDPLVDSLGSGIVYSALTCHL
CGHLKQCHGQEDGGQTPVMASPCCGCCCGDRSSPPTTPLRAPDPSPGGVPLEASLCPASLAPSGISEKSKSSSSFHPAPG
NAQSSSQTPKIVNFVSVGPTYMRVS
157
267
1IRS
157
267
P35568
A
1
2
112
489
499
1IRS
489
499
P24394
B
2
1
11
2
TYR
modified residue
PTR
497
1IRS
B
P24394
UNP
497
9
4
3
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
162
A
GLU
7
A
ILE
167
A
ILE
12
A
ILE
182
A
ILE
27
A
THR
188
A
THR
33
A
THR
191
A
THR
36
A
LYS
196
A
LYS
41
A
VAL
204
A
VAL
49
A
GLN
207
A
GLN
52
A
GLY
234
A
GLY
79
A
PHE
236
A
PHE
81
A
PHE
220
A
PHE
65
A
VAL
225
A
VAL
70
A
ILE
211
A
ILE
56
A
SER
217
A
SER
62
1
P 1